Skip to content
Home/Companies/Biotech/BioThrust

BioThrust

Biotech·Germany·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns BioThrust?

BioThrust is a German Biotech company, currently owned by Freigeist Capital since 2024.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Freigeist Capital
Investor
Freigeist Capital
Freigeist Deep-Tech Evergreen · 2017 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from Freigeist Deep-Tech Evergreen

Other portfolio companies in the same fund.

Zahnheld
Active
Germany· 2026
Akina
Akina
Active
MedTechSwitzerland· 2025
Collie
Collie
Active
SoftwareGermany· 2025
United Manufacturing Hub
Active
SoftwareGermany· 2024
Leko Labs
Active
ConstructionLuxembourg· 2022
Prosion
Prosion
Active
BiotechGermany· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns BioThrust?

BioThrust is currently owned by Freigeist Capital, through Freigeist Deep-Tech Evergreen, since 2024.

When did Freigeist Capital acquire BioThrust?

Freigeist Capital acquired BioThrust in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue